MAN1C1 and intrahepatic cholangiocarcinoma: Wei et al. demonstrated that the loss of MAN1C1 promotes CD133 glycosylation in intrahepatic cholangiocarcinoma cells, enhancing CD133‐FIP200 interaction and promoting tumorigenesis in intrahepatic cholangiocarcinoma [61].